2018Unpublished venueRequires access

UJI MUTU FISIK TABLET DAN DISOLUSI TERBANDING TABLET OFLOKSASIN GENERIK DENGAN INOVATOR

Yulian Chrisna Dyaswara

Open publisher page 0 citations

Abstract

Comparative dissolution test is dissolution test performed to show the similarity of dissolution profiles between test drugs and innovator drugs. The test is important to know or provide information on the dissolution profile equality between the innovator and the test drugs. BPOM requires comparative dissolution test based on Biopharmaceutic Classification System (BCS). Drugs that must be tested with comparative dissolution is ofloxacin. The purpose of this research is to know the similarity of dissolution profile and physical quality of generic ofloxacin tablet with innovator. Dissolution test of ofloxacin tablet using dissolution tool type 2 (paddle), rotation speed 50 rpm in 900 mL dissolution HCl pH 1,2 medium. Determination of dissolution rate using UV-Visible spectrophotometer at 294 nm wavelength. The test product used five ofloxacin 200 mg tablets on the market, ie 1 A innovator branded, 2 B and C branded, and 2 D and E generic product. The results of physical quality test of five products meet the requirements and provisions of good tablets. The dissolution profile of the test product shows the similarity of the dissolution profile of the innovator product, seen from the F1 parameter less than 15% and the F2 parameter above 50%. Test products and innovators fulfill the requirements of Pharmacope Indonesia edition III and United States Phamacopeia edition 32 Keywords : ofloxacin, physical quality test, comparative dissolution test

About this research paper

What this paper is about

Comparative dissolution test is dissolution test performed to show the similarity of dissolution profiles between test drugs and innovator drugs. The test is important to know or provide information on the dissolution profile equality between the innovator and the test drugs. BPOM requires comparative dissolution test based on Biopharmaceutic Classification System (BCS). Drugs that must be tested with comparative dissolution is ofloxacin. The purpose of this research is to know the similarity of dissolution profile and physical quality of generic ofloxacin tablet with innovator. Dissolution test of ofloxacin tablet using dissolution tool type 2 (paddle), rotation speed 50 rpm in 900 mL dissolution HCl pH 1,2 medium. Determination of dissolution rate using UV-Visible spectrophotometer at 294 nm wavelength. The test product used five ofloxacin 200 mg tablets on the market, ie 1 A innovator branded, 2 B and C branded, and 2 D and E generic product. The results of physical quality test of five products meet the requirements and provisions of good tablets. The dissolution profile of the test product shows the similarity of the dissolution profile of the innovator product, seen from the F1 parameter less than 15% and the F2 parameter above 50%. Test products and innovators fulfill the requirements of Pharmacope Indonesia edition III and United States Phamacopeia edition 32 Keywords : ofloxacin, physical quality test, comparative dissolution test

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Comparative dissolution test is dissolution test performed to show the similarity of dissolution profiles between test drugs and innovator drugs. The test is important to know or provide information on the dissolution profile equality between the innovator and the test drugs. BPOM requires comparative dissolution test based on Biopharmaceutic Classification System (BCS). Drugs that must be tested with comparative dissolution is ofloxacin. The purpose of this research is to know the similarity of dissolution profile and physical quality of generic ofloxacin tablet with innovator. Dissolution test of ofloxacin tablet using dissolution tool type 2 (paddle), rotation speed 50 rpm in 900 mL dissolution HCl pH 1,2 medium. Determination of dissolution rate using UV-Visible spectrophotometer at 294 nm wavelength. The test product used five ofloxacin 200 mg tablets on the market, ie 1 A innovator branded, 2 B and C branded, and 2 D and E generic product. The results of physical quality test of five products meet the requirements and provisions of good tablets. The dissolution profile of the test product shows the similarity of the dissolution profile of the innovator product, seen from the F1 parameter less than 15% and the F2 parameter above 50%. Test products and innovators fulfill the requirements of Pharmacope Indonesia edition III and United States Phamacopeia edition 32 Keywords : ofloxacin, physical quality test, comparative dissolution test

Key concepts: Innovator, Dissolution, Dissolution testing, Ofloxacin, Mathematics, Chemistry, Chromatography, Computer science

Back to paper searchBrowse research topicsOriginal source
UJI MUTU FISIK TABLET DAN DISOLUSI TERBANDING TABLET OFLOKSASIN GENERIK DENGAN INOVATOR — Research Paper | ScholarLens